...
首页> 外文期刊>Journal of the American Medical Directors Association >Prescription analgesic and antidepressant utilization and cost among elderly Medicaid beneficiaries before and after nursing home admission.
【24h】

Prescription analgesic and antidepressant utilization and cost among elderly Medicaid beneficiaries before and after nursing home admission.

机译:处方镇痛药和抗抑郁药用和在护理家庭入场前后的老年医疗会受益者的成本。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVES: The objectives of this study were to describe changes in prescription analgesic and antidepressant medications and to track the costs associated with these medication changes when elderly Medicaid beneficiaries move from the community to a nursing home setting. DESIGN: Retrospective analysis of Medicaid long-term care and drugs claims data for fiscal year 2000 from three different states. SETTING: Long-term care facilities in three different states. PARTICIPANTS: We studied 1321 elderly Medicaid beneficiaries newly admitted to a nursing home during the study period. MEASUREMENTS: Pain medications were grouped into four different categories and all antidepressants were grouped into one category. For each medication category, we obtained the number of unique patients for whom it was prescribed, the number of days it was prescribed, and the amount paid by Medicaid. We then calculated the percentage of subjects prescribed and the amount paid per day for each medication class before and after nursing home admission. RESULTS: Except for skeletal muscle relaxants, 21% to 39% of beneficiaries already had claims linked to each medication class while still living in the community. After nursing home admission, the percentage of beneficiaries exposed to each medication class increased by 2% to 33%. Cost per day of therapy increased by 10% to 83%. There was significant variation among the states in utilization and cost per day of therapy. CONCLUSIONS: We draw three major conclusions: (1) community-dwelling elderly Medicaid beneficiaries in this study use more prescription analgesics and antidepressants than community-dwelling elders in prior studies; (2) there is a significant increase in medication utilization and cost on nursing home admission; and (3) significant variability in medication use and cost exists among the three states examined. Further investigation to elucidate the reasons for these differences could assist legislators in formulating sound public policy to contain Medicaid expenditures without sacrificing patient care.
机译:目的:本研究的目标是描述处方镇痛和抗抑郁药物的变化,并追踪当老年医疗补助受益者从社区转移到护理家庭环境时,追踪与这些药物变化相关的成本。设计:从三个不同状态的2000财政年度的医疗补助长期护理和药物声称数据的回顾性分析。设置:三个不同状态的长期护理设施。参与者:我们研究了1321名老年医疗报案提案人,在研究期间新入院前往养老院。测量:将止痛药分为四种不同的类别,并将所有抗抑郁剂分为一个类别。对于每种药物类别,我们获得了规定的独特患者的数量,规定的天数,以及医疗补助所支付的金额。然后,我们计算规定的受试者的百分比和治疗家庭入场前后每种药物课程的每天支付的金额。结果:骨骼肌松弛剂除外,21%至39%的受益人已经涉及每个药物课程,同时仍然生活在社区。养老院后,暴露于每种药物课的受益人的百分比增加2%至33%。每天治疗成本增加10%至83%。各国在治疗中的利用率和成本中存在显着变化。结论:我们得出三个主要结论:(1)社区住宅的老年医疗提案剂在本研究中使用更多的处方镇痛药和抗抑郁药,而不是社区居住的长者在先前的研究中; (2)护理家庭入场的药物利用率和成本显着增加; (3)在检查的三种状态中存在药物使用和成本的显着变异性。进一步调查阐明这些差异的原因可以协助立法者在制定声音公共政策中,在不牺牲患者护理的情况下包含医疗补助商。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号